Sofinnova Partners related stories
All articles and analysis
A-Z of Healthcare: F-KThe second part of our A-Z looks at financing, growth, healthtech, infectious diseases, joint ownership and KOLs.
A-Z of Healthcare: A-EIn the first part of our A-Z, we examine ancillary healthcare, biotech, covid-19, digitisation and eldercare.
Sofinnova Partners raises $540mThe Paris-based asset manager has held a final close for its growth capital fund.
Sofinnova Partners raises €333mThe Paris-based venture capital firm closed its ninth healthcare fund.
Sofinnova Partners raises €48mThe European venture capital firm closes specialised life sciences fund.
- Sofinnova Partners raises €125m
The European venture capital firm closes largest European industrial biotech fund.
Sofinnova raises €106m for industrial biotech fundThe Paris-based life sciences specialist has held a first close on €106m for the fund, which is dedicated to renewable chemistry.
- Sofinnova collects €106m
View the latest capital raises
- Sofinnova closes Fund XIII on €300m
The lifescience investor topped its €250 million target tapping investors primarily in Europe and some in North America.
- Gilde Healthcare lists biopharma company
Ascendis Pharma gained $0.83 in its first day of trading after selling 6m shares at $18 per share